[Summary] Leading enterprise of the National Biological Industry Base
(1) Chongqing Lummy Pharmaceutical Co., Ltd. was listed on the ChiNext Board of the Shenzhen Stock Exchange on October 30, 2009 (stock code: 300006). It is a high-tech, group-managed pharmaceutical enterprise integrating research, production, and sales. Its product types include chemical drugs, active pharmaceutical ingredients, biological preparations, traditional Chinese patent medicines, and health products. It has several subsidiaries including Chayuan Formulation Plant, Changshou API Plant, Kangyuan Pharmaceutical, Jinxing Pharmaceutical, and Sichuan Hezheng Pharmaceutical, with approximately 2,000 employees currently.
(2) Overall strength of the company: From 2012 to 2015, it was successively rated as "*Innovative (Pilot) Enterprise", "China's Best Industrial Enterprise in Pharmaceutical R&D Product Line", "Chongqing Municipal Technology Innovation Demonstration Enterprise", and "Chongqing Municipal Intellectual Property Pilot Unit".
(3) R&D and innovation capability of the company: We focus on research and development, and innovative R&D is the company's core competitiveness. The company currently has an R&D team of about 130 people and possesses two R&D platforms: "Chongqing Lummy Pharmaceutical Technology Center" and "Lummy-Sichuan University Joint Laboratory". It also has a "Municipal-level Enterprise Technology Center" in Chongqing and a "Chongqing Drug Quality Control Engineering Technology Research Center" jointly established with the US-listed company Cell Genesys. After more than 10 years of development, in terms of scientific research and innovation, it has formed an independent innovation R&D platform represented by nano-drug technologies for lymphatic tracing, lymphatic-targeted chemotherapy, and tumor-targeted chemotherapy, a scientific research transformation technology platform represented by micron and nano dispersion technologies and sterile API preparation technologies, and a new drug generic platform represented by anti-infective drugs and specialty drugs. It has successfully applied for more than 200 patents, and its new drug applications rank among the top in Chongqing and even nationwide.
What does Chongqing Lummy Pharmaceutical Co., Ltd. require? Who is Lummy Pharmaceutical hiring? Lummy Pharmaceutical recruitment: 销售类占比最多占39.2%,其次是市场/公关/媒介类占29.4%. What education can get in at Lummy Pharmaceutical? 本科占比最多占48%,其次是大专占38.2%. High education required at Lummy Pharmaceutical? 硕士占5.9%. Work experience required at Lummy Pharmaceutical? 不限占比最多占52.9%,其次是3-5年占16.7%. Where are the job locations at Lummy Pharmaceutical? 重庆占比最多占54.9%,其次是成都占6.9%. Based on job postings from the past year, for reference only.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows